Matches in Wikidata for { <http://www.wikidata.org/entity/Q92749588> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q92749588 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92749588 description "scientific article published on 19 March 2019" @default.
- Q92749588 description "wetenschappelijk artikel" @default.
- Q92749588 description "наукова стаття, опублікована 19 березня 2019" @default.
- Q92749588 name "Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease" @default.
- Q92749588 name "Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease" @default.
- Q92749588 type Item @default.
- Q92749588 label "Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease" @default.
- Q92749588 label "Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease" @default.
- Q92749588 prefLabel "Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease" @default.
- Q92749588 prefLabel "Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease" @default.
- Q92749588 P1433 Q92749588-E17EC9A7-8B44-478C-A5DC-DE064E34ED89 @default.
- Q92749588 P1476 Q92749588-57289213-9655-42F5-8D0A-F4FC6B8E07CC @default.
- Q92749588 P2093 Q92749588-29933B7B-DBF4-4DDB-AA98-CAEE9B025F12 @default.
- Q92749588 P2093 Q92749588-492E66F1-D191-4BAE-B4D5-40F7E664BB9C @default.
- Q92749588 P2093 Q92749588-5F057A02-CF6D-4FB1-8D94-656D5C295063 @default.
- Q92749588 P2093 Q92749588-B6A54AB6-D147-443F-A6E2-7FF02825E9EB @default.
- Q92749588 P304 Q92749588-B3853CF4-970A-4BE2-B5FC-5E8408CDA7F1 @default.
- Q92749588 P31 Q92749588-8FB664E9-1EA2-4247-8558-1AFAB0B0DA29 @default.
- Q92749588 P356 Q92749588-6993CBDE-B8C3-48C9-95DC-6A6FED1D2461 @default.
- Q92749588 P478 Q92749588-3CB8C6DA-190A-460D-9D94-83387C28BC54 @default.
- Q92749588 P577 Q92749588-784EEE9D-F547-4136-B75E-B6A4723B851E @default.
- Q92749588 P698 Q92749588-AFF9299F-BCD2-4BF5-ABDE-497BB09BC0FA @default.
- Q92749588 P921 Q92749588-08A39A91-3C91-45BE-BD49-DCFA47558BD7 @default.
- Q92749588 P356 J.BIOORG.2019.03.032 @default.
- Q92749588 P698 30933785 @default.
- Q92749588 P1433 Q2904198 @default.
- Q92749588 P1476 "Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinson's disease" @default.
- Q92749588 P2093 "Karl-Norbert Klotz" @default.
- Q92749588 P2093 "Ranju Bansal" @default.
- Q92749588 P2093 "Sonja Kachler" @default.
- Q92749588 P2093 "Suman Rohilla" @default.
- Q92749588 P304 "601-612" @default.
- Q92749588 P31 Q13442814 @default.
- Q92749588 P356 "10.1016/J.BIOORG.2019.03.032" @default.
- Q92749588 P478 "87" @default.
- Q92749588 P577 "2019-03-19T00:00:00Z" @default.
- Q92749588 P698 "30933785" @default.
- Q92749588 P921 Q11085 @default.